Mandatory disclosure of pharmaceutical industry-funded events for health professionals.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19885393.
- Also identified by DOI 10.1371/journal.pmed.1000128 and PMC identifier 2764857.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
David Henry and colleagues examine compliance with new disclosure requirements of Medicines Australia, the pharmaceutical industry representative body, and argue that they fall short and instead more comprehensive reporting standards are needed.
Medical subject headings
- Disclosure
- Drug Industry
- Mandatory Programs
- Physicians